Index by author
Jabbour, P.
- NeurointerventionYou have accessLack of Association between Statin Use and Angiographic and Clinical Outcomes after Pipeline Embolization for Intracranial AneurysmsW. Brinjikji, H. Cloft, S. Cekirge, D. Fiorella, R.A. Hanel, P. Jabbour, P. Lylyk, C. McDougall, C. Moran, A. Siddiqui, I. Szikora and D.F. KallmesAmerican Journal of Neuroradiology April 2017, 38 (4) 753-758; DOI: https://doi.org/10.3174/ajnr.A5078
Jenkins, R.B.
- FELLOWS' JOURNAL CLUBAdult BrainOpen AccessGenetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRID.R. Johnson, F.E. Diehn, C. Giannini, R.B. Jenkins, S.M. Jenkins, I.F. Parney and T.J. KaufmannAmerican Journal of Neuroradiology April 2017, 38 (4) 678-684; DOI: https://doi.org/10.3174/ajnr.A5070
The authors wanted to determine whether imaging characteristics previously associated with oligodendroglial tumors were still applicable given the 2016 WHO classification that made IDH mutation and 1p/19q codeletion the defining features of oligodendroglioma. They found that 92% of genetically defined oligodendrogliomas had noncircumscribed borders, compared with 45% of non-1p/19q codeleted tumors with at least partial histologic oligodendroglial morphology. Ninety-nine percent of oligodendrogliomas were heterogeneous on T1- and/or T2-weighted imaging.
Jenkins, S.M.
- FELLOWS' JOURNAL CLUBAdult BrainOpen AccessGenetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRID.R. Johnson, F.E. Diehn, C. Giannini, R.B. Jenkins, S.M. Jenkins, I.F. Parney and T.J. KaufmannAmerican Journal of Neuroradiology April 2017, 38 (4) 678-684; DOI: https://doi.org/10.3174/ajnr.A5070
The authors wanted to determine whether imaging characteristics previously associated with oligodendroglial tumors were still applicable given the 2016 WHO classification that made IDH mutation and 1p/19q codeletion the defining features of oligodendroglioma. They found that 92% of genetically defined oligodendrogliomas had noncircumscribed borders, compared with 45% of non-1p/19q codeleted tumors with at least partial histologic oligodendroglial morphology. Ninety-nine percent of oligodendrogliomas were heterogeneous on T1- and/or T2-weighted imaging.
Jezzard, P.
- EDITOR'S CHOICENeurointerventionYou have accessFeasibility of Flat Panel Detector CT in Perfusion Assessment of Brain Arteriovenous Malformations: Initial Clinical ExperienceM. Garcia, T.W. Okell, M. Gloor, M.A. Chappell, P. Jezzard, O. Bieri and J.V. ByrneAmerican Journal of Neuroradiology April 2017, 38 (4) 735-739; DOI: https://doi.org/10.3174/ajnr.A5091
Five patients with brain arteriovenous malformations were studied with flat panel detector CT, DSC-MR imaging, and vessel-encoded pseudocontinuous arterial spin-labeling. Flat panel detector CT, which was originally thought to measure blood volume, correlated more closely with ASL-CBF and DSC-CBF than with DSC-CBV. Flat panel detector CT perfusion depends on the time point chosen for data collection, which is triggered early in patients with AVMs. This finding, in combination with high data variability, makes flat panel detector CT inappropriate for perfusion assessment in brain AVMs.
Johnson, D.R.
- FELLOWS' JOURNAL CLUBAdult BrainOpen AccessGenetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRID.R. Johnson, F.E. Diehn, C. Giannini, R.B. Jenkins, S.M. Jenkins, I.F. Parney and T.J. KaufmannAmerican Journal of Neuroradiology April 2017, 38 (4) 678-684; DOI: https://doi.org/10.3174/ajnr.A5070
The authors wanted to determine whether imaging characteristics previously associated with oligodendroglial tumors were still applicable given the 2016 WHO classification that made IDH mutation and 1p/19q codeletion the defining features of oligodendroglioma. They found that 92% of genetically defined oligodendrogliomas had noncircumscribed borders, compared with 45% of non-1p/19q codeleted tumors with at least partial histologic oligodendroglial morphology. Ninety-nine percent of oligodendrogliomas were heterogeneous on T1- and/or T2-weighted imaging.